There are disclosed a .beta.-lactam compound represented by the formula (I): ##STR1## wherein R.sub.1 and R.sub.2 are independently a hydrogen atom or a lower alkyl group; M is a hydrogen atom, a protective group or an eliminatable group which is easily hydrolyzable in a human body; R' and R" are independently a hydrogen atom or a protective group; A is a mercapto group substituted by a substituted or unsubstituted polycyclic nitrogen-containing heterocyclic ring or a group represented by the following formula (a): --OOCNR.sub.3 R.sub.4 (a) where R.sub.3 and R.sub.4 are independently a hydrogen atom or a lower alkyl group, provided that R.sub.1 and R.sub.2 are both hydrogen atoms, both R.sub.3 and R.sub.4 being hydrogen atoms are excluded, or its pharmaceutically acceptable salt, and a method for preparing the same , medicinal composition for microbism therapy containing the same and intermediates for synthesis of the same.
公开了一种β-内酰胺化合物,其
化学式为(I):##STR1##其中R₁和R₂分别为氢原子或较低的烷基基团;M为氢原子、保护基或易在人体中
水解的可消除基团;R'和R"分别为氢原子或保护基;A为经取代或未取代多环氮杂
环烃环取代的巯基或以下式(a)所表示的基团:--OOCNR₃R₄(a),其中R₃和R₄分别为氢原子或较低的烷基基团,前提是R₁和R₂均为氢原子,排除R₃和R₄均为氢原子的情况,或其药学上可接受的盐,以及制备该化合物的方法、含有该化合物的微
生物治疗药物组合物和合成该化合物的中间体。